Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1991-07-15
1992-07-14
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 89, 514 90, 540542, 540575, 544125, 544337, 544365, 546 21, 546193, 546194, 546256, 546257, 546263, A61K 3144, A61K 3155, A61K 31535, A61K 31675
Patent
active
051303035
ABSTRACT:
Compounds of the formula (I): ##STR1## in which the nitrogen-containing hetero ring portion is a 1,4-dihydropyridine ring or a pyridine ring, R.sup.1 is only present when the nitrogen-containing hetero ring is a 1,4-dihydropyridine ring, and Z is either a CO.sub.2 R.sup.8 group or a group of the formula (II): ##STR2## in which R.sup.4 and R.sup.5 may be the same or different and together may form one divalent group, are effective agents for enhancing the antitumor effect or antitumor drugs.
REFERENCES:
patent: 3485847 (1969-12-01), Bossert et al.
patent: 3644627 (1972-02-01), Bossert et al.
patent: 3985758 (1976-10-01), Murakami et al.
patent: 4340718 (1982-07-01), Zannucci et al.
patent: 4393070 (1983-07-01), Sato et al.
patent: 4535073 (1985-08-01), Kimura et al.
patent: 4576934 (1986-03-01), Seto et al.
patent: 4839361 (1989-06-01), Seto et al.
patent: 4843076 (1989-06-01), Seto et al.
patent: 4845113 (1989-07-01), Gandolfi et al.
patent: 4857515 (1989-08-01), Kimura et al.
patent: 4885284 (1989-12-01), Seto et al.
patent: 4963560 (1990-10-01), Cooper et al.
Kamiwatari et al., Cancer Research, vol. 49, pp. 3190-3195, Jun. 15, 1989.
Chem. Abstract vol. 107: 147360d (1987), Wayne State U.
Chemical Abstracts 96: 217395z, Samarenko (1982).
Chemical Abstracts 86: 189726f, Sato (1977).
Chemical Abstracts 89: 109132h, Sato (1978).
Chemical Abstracts 93: 220594g, Sato (1980).
Chemical Abstracts 96: 6590w, Sato (1981).
Chemical Abstracts 98: 160590u, Miyano (1982).
Chemical Abstracts 80: 145813d, Grisar (1974).
Chemical Abstracts 87: 23493y, Hofer (1977).
Chemical Abstracts 87:67963f, Hofer (1977).
Chemical Abstracts 94: 174894a, Sanyo Chem. (1980).
Chemical Abstracts 94: 139473r, Oriental Photo (1980).
Chemical Abstracts 104: 34013n, Culbertson (1985).
Chemical Abstracts 110: 94399b, Sicker (1988).
Chemical Abstracts 110: 7626g, Asokan (1988).
Chemical Abstracts 106: 207674a, Partis (1987).
Chemical Abstracts 102: 184973y, Watson (1984).
Chemical Abstracts 93: 186175j, Sato (1990).
Chemical Abstracts 77: 140110a, Bisagni (1972).
Chemical Abstracts 98: 34509m, Campbell (1982).
Chemical Abstracts 99: 121828d, Sankyo Co. (1983).
Chemical Abstracts 106: 32329n, Seebach (1986).
Chemical Abstracts 110: 231441a, Cooper (1988).
Chemical Abstracts 103: 37282q, Haebich (1985).
Chemical Abstracts 101: 38272g, Yamamoto (1984).
Chemical Abstracts 103: 123252m, Haebich (1985).
Chemical Abstracts 98: 215472q, Miller (1982).
Chemical Abstracts 98: 178749n, Miller (1982).
Chemical Abstracts 100: 51576h, Vogel (1983).
Chemical Abstracts 102: 203617d, Banyu Ph. (1984).
Chemical Abstracts 101: 23346k, Miyano (1984).
Chemical Abstracts 108: 37664u, Semeraro (1987).
Chemical Abstracts 110: 108190r, Flockerz; (1988).
Synth. Commun 18(10)1133 (1988), Acuna et al.
J. Med. Chem; 20, 781 (1977), Parker et al.
J. Org. Chem; 44, 310 (1979), Wierenza et al.
Tetrahedron Lett; 32, 2757-2760 (1976), Hartzell et al.
Synth. Commun., 18(9), 949, (1988), Peterson et al.
Chem. Lett., (2), 161-4, (1975), Izawa et al.
J. Chem. Soc. Chem. Commun (10) 722-4 (1987), Takahashi et al.
J. Chem. Soc. Chem., Commun (13) 578-9 (1979), Chan et al.
J. Org. Chem., 42, 525 (1977), Secrist III et al.
J. Chem. Soc Perkin Trans I, (7), 1241-52 (1989), Muraoka et al.
Tetrahedron Lett., vol. 25, pp. 4545-8 (1984); Yamamoto et al.
Merck Index, 9th Ed. p. 554. (1976).
Chem. Pharm Bull., vol. 28, pp. 3163-3171 (1980); Aritomi et al.
Hannick et al, J. Org. Chem., vol. 48, p. 3833 (1983).
Journal of Medicinal Chemistry, vol. 17, No. 9, Sep. 1974, pp. 956-965.
Akiyama Shin-ichi
Sakoda Ryozo
Seto Kiyotomo
Shudo Norimasa
Datlow Philip
Nissan Chemical Industries Ltd.
Shah Mukund J.
LandOfFree
Drug effect-enhancing agent for antitumor drug does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug effect-enhancing agent for antitumor drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug effect-enhancing agent for antitumor drug will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-334729